Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

BC038925 Inhibitors

Chemical inhibitors of BC038925 can exert their inhibitory effects through various biochemical pathways. Staurosporine serves as a broad-spectrum protein kinase inhibitor, which can inhibit the phosphorylation processes that are critical for BC038925's activity within the cell. By halting these phosphorylation events, staurosporine can directly inhibit the functional activity of BC038925. LY294002, another chemical inhibitor, specifically blocks the PI3K/Akt pathway. This pathway is known to play a significant role in a multitude of cellular functions, and by inhibiting it, LY294002 can decrease the cellular signals that regulate BC038925's activity. Similarly, rapamycin, by inhibiting the mTOR pathway, can reduce the functions associated with BC038925, particularly those related to cell growth and proliferation, leading to a functional inhibition of BC038925.

In addition to these, PD98059 and SB203580 target the MAPK signaling cascade, with PD98059 selectively inhibiting MEK1, which is upstream of ERK, and SB203580 targeting p38 MAP kinase. Both of these kinases are involved in cellular responses to stress and inflammation and can regulate the activity of BC038925. PP2 and dasatinib serve as inhibitors of Src family kinases, which are known to be involved in the regulation of various proteins, including BC038925. By inhibiting these kinases, PP2 and dasatinib can decrease the activation and regulation of BC038925. Sorafenib, targeting RAF kinases, also exerts its inhibitory effect within the MAPK pathway, which can be central to BC038925's role in the cell. SP600125 inhibits JNK signaling, further diminishing the pathways that control BC038925's function. ZM447439, by targeting Aurora kinase, can affect cell cycle regulation processes that BC038925 may be involved in, leading to its inhibition. Lestaurtinib inhibits JAK2 kinase and consequently the JAK-STAT signaling pathway, which may regulate BC038925. Lastly, PD173074, by targeting FGFR kinase, disrupts signaling pathways that are key in the regulation of BC038925, achieving functional inhibition. Each chemical plays a role in tightly regulated pathways that govern the cellular functions wherein BC038925 is active, and by inhibiting these pathways, they achieve the functional inhibition of BC038925.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Inhibits protein kinases that could be crucial for the phosphorylation processes regulating BC038925 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Blocks the PI3K/Akt pathway, which may be essential for signaling functions that regulate BC038925.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR pathway, potentially reducing functions associated with BC038925 involved in cell growth and proliferation.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Inhibits MEK1, which could be involved in the ERK/MAPK pathway, potentially regulating BC038925 activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibits p38 MAP kinase, potentially disrupting cellular processes that BC038925 is implicated in.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

Inhibits Src family kinases, which may play a role in activating or regulating BC038925.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Inhibits Src family kinases and Bcr-Abl, potentially decreasing activation or regulation of BC038925.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Targets RAF kinases within the MAPK signaling cascade that could be involved in the regulation of BC038925.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK signaling, potentially affecting the pathways that control BC038925's function.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$150.00
$349.00
15
(1)

Inhibits Aurora kinase, potentially affecting cell cycle regulation processes that BC038925 may be a part of.